Recognitions on Sustainable Technologies, Dividend Authorizations, Earnings Results, and Leadership Transitions - Analyst Notes on Dow, FMC, Eastman, Huntsman and Celanese

NEW YORK, May 13, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), FMC Corp. (NYSE: FMC), Eastman Chemical Co. (NYSE: EMN), Huntsman Corporation (NYSE: HUN) and Celanese Corporation (NYSE: CE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2350-100free.

The Dow Chemical Company Analyst Notes
On May 2, 2014, The Dow Chemical Company (Dow) announced that it has been the recipient of the Bronze Edison Award for the FILMTEC ECO Reverse Osmosis Elements in the Energy/Sustainability and Commercial Resource Management category. The award recognizes the technology's ability to significantly reduce the energy required to remove impurities from water. "Energy consumption is the number one controllable resource in the water-energy nexus," said Snehal Desai, Global Business Director for Dow Water & Process Solutions. "The Edison Award recognition is very important to us, as it shows our technologies and innovations, like FILMTEC ECO Reverse Osmosis Elements, are making impacts on real-world issues like water and energy scarcity." The FILMTEC ECO technology was also named as the Company's second-ever Breakthrough to a World Challenge as part of its 2015 Sustainability Goals. The full analyst notes on Dow are available to download free of charge at:

http://www.analystsreview.com/2350-DOW-13May2014.pdf

FMC Corp. Analyst Notes
On April 29, 2014, FMC Corp. (FMC) announced that its Board of Directors has approved and declared a quarterly dividend in the amount of $0.15 per share. The dividend is payable on July 17, 2014, to shareholders of record at the close of the business on June 30, 2014. The full analyst notes on FMC are available to download free of charge at:

http://www.analystsreview.com/2350-FMC-13May2014.pdf

Eastman Chemical Co. Analyst Notes
On May 1, 2014, Eastman Chemical Co. (Eastman) announced that its Board of Directors has approved and declared a quarterly dividend in the amount of $0.35 per share on the Company's stock. The dividend is payable on July 1, 2014, to stockholders of record as of June 13, 2014. The full analyst notes on Eastman are available to download free of charge at:

http://www.analystsreview.com/2350-EMN-13May2014.pdf

Huntsman Corporation Analyst Notes
On April 29, 2014, Huntsman Corp. (Huntsman) reported its Q1 2014 financial results with revenues of $2.8 billion, up 2.0% YoY. Net income attributable to Huntsman totaled $54 million or $0.22 per diluted share, compared to a net loss of $24 million or $0.10 per diluted share in Q1 2013. Peter R. Huntsman, President and CEO, commented, "Our first quarter results demonstrated broad earnings strength as all of our businesses exceeded the previous year with the exception of PO/MTBE." He continued, "The benefits of our previous year's restructuring efforts are visible in both our Advanced Materials and Textile Effects results. We continue to see strong results in our Performance Products and MDI polyurethanes, which make up the core of our earnings." The full analyst notes on Huntsman are available to download free of charge at:

http://www.analystsreview.com/2350-HUN-13May2014.pdf

Celanese Corporation Analyst Notes
On May 8, 2014, Celanese Corp. (Celanese) announced the exit and retirement of Steven Sterin as the Company's Chief Financial Officer. Chris Jensen, Senior Vice President, Finance and Chief Accounting Officer, will assume the position as interim Chief Financial Officer. "I want to thank Steven for his contributions to Celanese over the last eleven years," said Mark Rohr, Chairman and CEO. "I support his desire to pursue broader leadership opportunities. We have a very capable internal leader, Chris Jensen, in the role of interim chief financial officer. We will start an external search shortly." The full analyst notes on Celanese are available to download free of charge at:

http://www.analystsreview.com/2350-CE-13May2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.analystsreview.com/

SOURCE Analysts Review